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In the course of the next 10 years, say the watchers of
consumer trends, a new generation—Generation C—will
emerge. Born after 1990, they are referred to as “digital
natives,” now beginning to attend university and enter the
workforce, they are expected to transform the world as we
know it [1]. The “C” stands for “connected,” “communicat-
ing,” “content-centric,” “creative,” and “change”; however, it
may just as well stand for “centenarian” as for the ﬁrst time
in history many of this birth cohort will live 100 years or
more. The fact is that people are living longer and generally
healthier lives than ever before. Mortality, and by some
measures incident morbidity and disability, is being delayed
considerably in today’s elderly [2]. As a result, centenarians,
once considered rare, are now becoming commonplace.
Indeed, they are the fastest growing demographic group
of the world’s population, their numbers having roughly
doubled every decade since 1950, and they are globally
projectedtomorethanquintuplebetween2005and2030[3].
According to some estimates [3], the odds of living to
one hundred have risen from approximately 1 in 20 million
t o1i n5 0f o rw o m e ni ns o m el o w - m o r t a l i t yn a t i o n s .I f
progress in reducing mortality continues at the same pace
as it has over the past two centuries, which is still being
debated [2, 4, 5], many, if not most, children born today in
low-mortality countries can expect to become centenarians
[6]. The US Social Security Administration [7] forecasts the
number of centenarians in the US to surpass one million
before the end of this century. Generation C will indeed be
in full bloom.
This unprecedented phenomenon is largely the result
of signiﬁcant public health advancements that markedly
reduced early life mortality, principally due to interventions
that reduced infectious diseases in the ﬁrst decades of the
20th century [4]. Lasting eﬀects of such interventions from
less lifetime inﬂammation, and other ancillary beneﬁts, may
have contributed [8]. More recently we have seen marked
reductions in morbidity and mortality at older ages [9].
Less well understood, these late life health improvements
coincide with the aging of younger cohorts who practiced
healthier behaviors and had access to better medical care
[10]. The culmination of these advances has resulted in the
most rapid health improvement in the history of humanity.
Centenarians, once rare, are now living testaments to these
remarkable health advancements [11].
Despite the mounting weight of scientiﬁc evidence for
the impending appearance of a new generation of oldest old
and, moreover, one that might rival Generation X, Y or the
baby boomers in social signiﬁcance, the global implications
of this phenomenon have yet to be fully appreciated. Nor
havefundingagenciesinmostnations,untilrecently,realized
the value of investing research resources on the study of
the oldest old [12]. In fact, the older population (including
“young-old” aged 65–75 years) was formerly systematically
excluded from clinical trials [13]. Indeed, many of the rare2 Current Gerontology and Geriatrics Research
and valuable prospective cohort studies on older adults that
exist today were not begun as studies of aging. Instead,
younger cohorts were followed for decades for other phe-
notypes, such as cardiovascular diseases, when prescient
researchers and funding bodies began to add aging-related
variables, phenotypes, and outcomes. Two such examples
are the Honolulu Heart Program [14] and the Framingham
Heart Study [15], each with over four decades of extensive
followup and several ancillary studies of aging.
Since centenarian studies, like most centenarians them-
selves, have been a phenomenon of only the past several
decades, there has been no large repository of prior biologi-
cal, psychosocial, demographic, genetic, or clinical data from
which to inform researchers, policy makers, or clinicians.
Fortunately, this situation has begun to change in recent
years, and centenarian studies, once in their infancy, are
now themselves beginning to mature. Indeed, the world’s
longest continuously running centenarian study, the Oki-
nawa Centenarian Study, began in 1975 and is now entering
its fourth decade. The longest running centenarian study
in the USA, the Georgia Centenarian Study [16], recently
celebrated its 20th anniversary by hosting a conference with
diﬀerent centenarian research teams from around the world
[17]. Representatives from the Ashkenazi Jewish, Chinese,
Danish, French, Georgia, Hawaii, Korean, New England,
Okinawa, and Tokyo centenarian studies, as well as the NIA
Longevity Consortium, gathered to share information at this
conference, many of whom also made contributions to the
current special issue. Other major studies have been ongoing
for a considerable period of time in Italy, Sweden, Germany,
and other areas of the world.
There is no doubt that centenarian studies are quickly
maturing with over a dozen major studies now operational
worldwide for a decade (or more) [18] and several more
either recently begun or in the planning stages. Therefore, it
is timely that the manuscripts in this special issue exemplify
the progress being made in this ﬁeld.
Past work from centenarian studies has illuminated
the ﬁeld of aging with important discoveries. A brief and
necessarilyimperfectsurveyofsomesuchhighlightsincludes
the key area of genetics of aging and longevity, where the
ﬁrst so-called “longevity-associated genes” emerged in the
1980s from the study of HLA polymorphisms in Okinawans
[19]. Several years later, in the mid-1990s, APOE emerged
[20] and was later widely replicated (for review see [21,
22]). Subsequently, there appeared genome-wide association
studies (GWAS) as we ushered in the 2000s. As yet, there has
been little replication of early GWAS ﬁndings [23, 24]. This
maybedue,inpart,tostatisticallimitationsofGWASstudies
that require substantially larger sample sizes of the very old
for adequate power. This has led to ever larger consortia for
meta-analyses and related studies [25–27].
More recent advances in genotyping methodology have
allowed for sophisticated, rapid, and inexpensive SNP geno-
typing, targeted DNA sequencing, and large-scale “deep”
sequencing, particularly around “hot” genomic areas. Such
developments are helping facilitate rapid discovery as well as
rapid replication studies. For example, the original discovery
that the evolutionarily conserved FOXO3A gene is important
to healthy aging and longevity in humans was found in long-
lived Japanese-Americans in Hawaii [28] and within a year
w a sr e p l i c a t e di nG e r m a na n dF r e n c h[ 29], and Italian [30]
centenarian populations as well as three other independent
cohorts of oldest old [31]. Multiple other replications
followed within 2 years [22]. Other promising gene variants,
such as those within the CETP gene, may be population
speciﬁc since to date robust ﬁndings have only appeared
in Ashkenazi Jews [32] and Japanese-Americans [33]a n d
t h e yi n v o l v e dc o m p l e t e l yd i ﬀerent gene variants that were
either very rare or did not exist in the other population—
buthavebroadlysimilarbiologicaleﬀects.Therewilllikelybe
other such discoveries inspired by evolutionarily conserved
biological pathways from model organisms of aging [34].
“Epigenetics,” various “omics,” and “mimetics,” much of it
inspired by model organism research, is also rapidly coming
to studies of aging humans, and centenarian studies will be
at the forefront of this new research tide [35].
A small sample of other important ﬁndings includes the
discovery that centenarian families also seem to be longer-
lived and healthier than the rest of us [36]. Centenarians
appear to have brothers and sisters, as well as children,
who tend to live longer with lower risk for age-associated
disease [37, 38]. Population-based studies have revealed that
centenarians are overwhelmingly female except in rare areas
of the world [39]. Yet despite their superiority in numbers,
phenotypic characterization has revealed that the few males
who do live to 100 tend to have higher levels of functioning
when compared to their female counterparts. Exploring
the centenarian phenotype has been of great interest, and
understanding aging-related phenotypes has taken on new
importance for the gerontological research agenda [40–42].
Multiple studies (we introduce a few examples and concen-
trate on review papers) of centenarians have helped quantify
and characterize the phenotype of exceptional survivors in
terms of aging biomarkers, biochemistry, nutritional status
and anthropometry [43–47], inﬂammation [48–50], cardio-
vascularrisk proﬁles [51], physicalandcognitive functioning
[52–57], morbidity proﬁles [58], personality traits [59],
amongotheraging-relatedphenotypes[42,60].Psychosocial
studies have shown that adaptation to the challenges of aging
is also a key protective factor for healthy aging and longevity
(see a review of key ﬁndings in this special issue, by L. W.
Poon et al., (2010). This is a mere sprinkling of ﬁndings from
the numerous manuscripts now available from centenarian
studies. This important body of work has helped shape the
gerontological research knowledge base and has set a wider
agenda for aging research.
The current special issue helps build on this knowledge
base and begins with two important manuscripts that have
focused upon the demographic characteristics of this new
emerging generation of centenarians. The ﬁrst manuscript,
by R. D. Young et al. (2010) begins by challenging commonly
held ideas (both by the lay public and by researchers) regard-
ing exceptional longevity and builds preliminary typologies
of extreme longevity myths based upon both ﬁeld experience
investigating claims to extraordinary longevity and data
analysis of American Social Security Death Index ﬁles of
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sobering. Despite extraordinary claims to exceptional longe-
vity regularly surfacing in the media and even in respected
scientiﬁc journals, the majority of age claims over the age
of 110 years, and nearly all over the age of 115 years, have
turned out to be false. Acceptance of such extraordinary ages
without adequate skepticism and evaluation (age validation)
undermines responsible scientiﬁc research, journalism, and
public knowledge in this ﬁeld. The second manuscript in
the issue, by J. Robine et al. (2010), aims to specify the
level of mortality selection among centenarians from 5 low-
mortality countries (Denmark, France, Japan, Switzerland
and Sweden) all part of the 5-Country Oldest Old Project (5-
COOP). Three levels of mortality selection were discovered:
a milder level in Japan, a stronger level in Denmark and
Sweden,andanintermediatelevelinFranceandSwitzerland.
These diverging trends oﬀer an opportunity to study the
existence of a trade-oﬀ between the levels of mortality
selection and the functional heath status of the oldest old in
low-mortality countries.
The next two manuscripts in the special issue deal with
predictors and dynamic determinants of healthy aging and
longevity.J.Arnoldetal.(2010)employedmorbidity proﬁles
(originally developed by [58]) for their population-based
sample from the Georgia Centenarian Study, to determine
proportions of centenarians reaching 100 years as survivors
(43%), delayers (36%), or escapers (32%) of chronic, age-
associated diseases. Diseases fell into two morbidity clusters,
one that involves diseases such as CVD, cancer, anemia, and
osteoporosis and another associated with dementia. Major
barriers to reaching centenarian status in a “healthy state”
come from several incident chronic age-related diseases—
increasing cancer risk from their sixties, cardiovascular risk
from their seventies, and dementia risk from their eighties.
Interestingly, 43% of centenarians in this population-based
study managed to escape a clinical diagnosis of dementia,
and, in concert with other studies of the oldest old, few
had suﬀered from cancer. Consistent with their model of
developmental adaptation, distal life events contributed to
predicting survivorship outcome. Morbidity classiﬁcation
and health status appeared as critical adaptation variables in
very late life. A. I. Yashin et al. (2010) in their manuscript
on dynamic determinants of longevity, utilize data from
the Framingham Study to assess longitudinal changes in
physiological indices such as BMI, diastolic blood pressure,
pulse pressure, pulse rate, blood glucose, hematocrit, and
serum cholesterol. Their primary aim was to investigate the
possibilitythatdynamicpropertiesofagetrajectoriesofthese
physiological indices could be important contributors to
morbidityandmortality.Theauthorsshowedthatindeedthe
rate of change in physiological state between forty and sixty
years served as a good predictor of morbidity and mortality
risk later in life and that the rates of decline after reaching
the maximum, the actual maximal value itself, and the
age at which maximal values were reached were important
predictors of morbidity and mortality risk.
The next two manuscripts of the special issue focus upon
assessment of physical capabilities of middle-aged adults,
older adults, and the exceptionally old (centenarians). C. D.
Ceria-Ulep et al. (2010) investigate the reliability and cor-
relations with age of the balance components of the EPESE
and NHANES tests and the Good Balance Platform System
(GBPS) in a normal population of adults. It was found
that the EPESE and NHANES batteries of tests were not
suﬃciently challenging to allow successful discrimination
among subjects in good health, even older subjects. The
GBPS allowed objective quantitative measurements but had
low reliability coeﬃcients except for the most diﬃcult testing
conditions. Both height and body fat were associated with
GBPS scores necessitating adjusting for these variables if
using balance as a predictor of future health, particularly
in a population witnessing ever-increasing obesity. Assessing
physical performance in middle-aged and older adults may
be challenging but the broad variation in physical abilities
(from independence to bed-bound immobility) found in
centenarians makes it extremely diﬃcult to evaluate function
using a single instrument. A. E. Cress et al. (2010) utilize
data from a population-based sample of 244 centenarians
and80octogenarianstoprovidenormsontheShortPhysical
Performance Battery and extend the range of this scale
using performance on additional tasks and item response
theory (IRT) models, reporting information on concurrent
and predictive validity of this approach. Using the original
SPPB scoring criteria, 73% of centenarian men and 86% of
centenarian women were identiﬁed as severely impaired by
the scale’s original classiﬁcation scheme. Results suggest that
conventional norms for older adults need substantial revi-
sion for exceptionally old persons, such as near centenarians
andcentenarians,andthatitemresponsetheorymethodscan
be helpful to address ﬂoor and ceiling eﬀects found with any
single measure.
The next three manuscripts in the special issue deal with
biologicalphenotypesofcentenarians.Whatdocentenarians
look like underneath the skin? A. von Gunten et al. (2010), in
a review article, explore brain aging in the oldest old reveal-
ing that pathological substrates of cognitive deterioration,
such as the patterns of lesion distribution and neuronal loss,
seem to be diﬀerent in the oldest old compared to those
observed in the younger old. In contrast to younger ages
where dementia is mainly related to severe neuroﬁbrillary
tangle (NFT) formation within adjacent components of the
medial and inferior aspects of the temporal cortex, the oldest
old tend to display a preferential involvement of the anterior
part of the CA1 ﬁeld of the hippocampus, whereas the
inferior temporal and frontal association areas are relatively
spared. The authors suggest that microvascular parameters
such as mean capillary diameters may be key factors to con-
sider for the prediction of cognitive decline in the oldest old.
In the next manuscript, M. Suzuki et al. (2010) investi-
gated blood lipid peroxidation and the role of tocopherols in
oxidative stress and longevity among Okinawan centenari-
ans. Oxidative stress, inﬂammation, and aging are intimately
linked biological processes that are partly mediated by
nutritional status. Finding micronutrients or other natural
compounds that might protect against age-related diseases
or might slow aging itself is of great interest. Suzuki and
colleagues’ ﬁnding of low plasma levels of lipid peroxides in
centenarians compared to younger controls argues for pro-
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and is consistent with predictions of the Free Radical Theory
of Aging. However, the study did not strongly support a
role for vitamin E in this phenomenon. One intracellular
tocopherol subtype (beta) was found to be signiﬁcantly
higher in centenarians and may deserve further study. In
the next manuscript, C. S. Kwak et al. (2010) do interesting
detective work to unravel the mystery of vitamin B12 status
in Korean centenarians. They ask how it is possible for
Korean centenarians, who ate minimal animal products over
the course of their lives, to do relatively well in terms
of avoiding vitamin B12 deﬁciency, a common problem
for older people everywhere. The researchers discovered
that the traditional plant-based Korean diet consumed
by the centenarians was actually providing them with a
considerable amount of this important nutrient and, upon
screening, found fermented soybean foods such as kimchee
and seaweeds to be potent sources of vitamin B12.
Finally, the last two manuscripts in this special issue
focus upon the much neglected role of psychosocial factors
in reaching centenarian status. Y. Zeng et al. (2010), using
a unique data set from the Chinese Longitudinal Healthy
Longevity Survey and the largest sample to date of centenar-
ians, show that Chinese centenarians, as reﬂected in survey
response items emphasizing coping and adjustment (such
as personal tenacity, optimism, coping with negative moods,
secure relationships, and self-control), are signiﬁcantly more
resilient than younger elders in their 90s, 80s or 70s. Their
results argue for policies and programs that might promote
thischaracteristic.Thelastmanuscriptinthespecialissue,by
L. W. Poon et al. (2010), ties the issue together by examining
the contributions of psychosocial dynamics to health and
qualityoflifeandarguingfortheimportanceofanintegrated
biopsychosocial approach to the study of longevity and
centenarians. The authors highlight recent data to demon-
strate the impact of four pertinent psychosocial domains
for future longevity research: (1) demographics, life events,
and personal history; (2) personality; (3) cognition; (4)
socioeconomic resources and support systems. L. W. Poon
et al. (2010) recommend that the above items supplement
the 2001 NIA Panel on the Characterization of Participants
in Studies of Exceptional Survival in Humans [41] that was
originally developed to provide guidelines on measures that
are important for studies of exceptional survival.
This ﬁne collection of manuscripts will no doubt add
importantinsightstothegrowingknowledgebaseintheﬁeld
of gerontology. As more and more of the global population
joins Generation “C”, understanding what happens on the
right tail of the survival curve will be critical for improving
the quality of life of these special elders and, indeed, should
help all of our elderly population. Centenarian studies have
and will continue to be important contributors to the
research agenda in aging and will no doubt yield more key
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